Resource Center
Emmes possesses deep experience in clinical research which we leverage on behalf of our clients. It is through our collaborative efforts with you that Emmes has conducted over 2,150 clinical trials and published 2,300+ peer-reviewed articles.
In this section of our site, we share our experience and publications with you as a tribute to our ongoing collaboration.
Resources
Publications
Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants with Hemiretinal Vein Occlusion Compared With Participants with Central Retinal Vein Occlusion (SCORE2) Report 18
2022 05 01
Scott, I.U., Oden, N.L., VanVeldhuisen, P.C., Ip, M.S., Blodi, B.A.
Successful Implementation of Substance Use Screening in Rural Federally-Qualified Health Centers Identified High Rates of Unhealthy Alcohol, Cannabis, and Tobacco Use
McNeely, J., McLeman, B., Gardner, T., Nesin, N., Farkas, S., Wahle, A., Pitts, S., Kline, M., King, J., Rosa, C., Marsch, L., Rotrosen, J., Leah, H.
A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial
2022 Jul 12
Bashir, Q., Nishihori, T., Pasquini, M.C., Martens, M.J., Wu, J., Alsina, M., Anasetti, C., Brunstein, C., Dawson, P., Efebera, Y., Gasparetto, C., Geller, N., Giralt, S., Hall, A.C., Koreth, J., McCarthy, P., Scott, E., Stadtmauer, E.A., Vesole, D.H., Hari, P.
Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial.
2020 09
Stephenson, K.E., Tan, C.Sabrina, Walsh, S.R., Hale, A., Ansel, J.L., Kanjilal, D.G., Jaegle, K., Peter, L., Borducchi, E.N., Nkolola, J.P., Makoni, T., Fogel, R., Bradshaw, C., Tyler, A., Moseley, E., Chandrashekar, A., Yanosick, K.E., Seaman, M.S., Eckels, K.H., De La Barrera, R.A., Thompson, J., Dawson, P., Thomas, S.J., Michael, N.L., Modjarrad, K., Barouch, D.H.
Evaluation of HIV-1 neutralizing and binding antibodies in maternal-infant transmission in Thailand.
2020 09
Wieczorek, L., Peachman, K., Adams, D.J., Barrows, B., Molnar, S., Schoen, J., Dawson, P., Bryant, C., Chenine, A.L., Sanders-Buell, E., Srithanaviboonchai, K., Pathipvanich, P., Michael, N.L., Robb, M.L., Tovanabutra, S., Rao, M., Polonis, V.R.
Lessons Learned from Early Closure of a Clinical Trial for Steroid-refractory Acute GVHD
2022 02
Meyers, G., Hamadani, M., Martens, M., Ali, H., Choe, H., Dawson, P., Harris, A.C., van Hooren, E., Klaassen, W., Leifer, E., MacMillan, M.L., van Oosterhout, Y., Perez, L., Pusic, I., Vo, P., Levine, J.E.
A Phase I Randomized, Double-blind, Single Subcutaneous Dose Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of Rezafungin in Healthy Adult Subjects
Jul2022
Gu, K., Ruff, D., Key, C., Thompson, M., Jiang, S., Sandison, T., Flanagan, S.
Monocyte and CD4+ T-cell antiviral and innate responses associated with HIV-1 inflammation and cognitive impairment.
2020 07 15
Sharma, V., Bryant, C., Montero, M., Creegan, M., Slike, B., Krebs, S.J., Ratto-Kim, S., Valcour, V., Sithinamsuwan, P., Chalermchai, T., Eller, M.A., Bolton, D.L.